How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer (Q30777425)

26 June 2017

How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer (English)

1 reference

26 June 2017

0 references

1 reference

1 reference

Ali Montazeri

1

0 references

author name string

Robert Milroy

2

1 reference

26 June 2017

David Hole

3

1 reference

26 June 2017

James McEwen

4

1 reference

26 June 2017

Charles R Gillis

5

1 reference

26 June 2017

1 March 2003

1 reference

26 June 2017

Quality of Life Research

1 reference

26 June 2017

12

1 reference

26 June 2017

2

1 reference

26 June 2017

157-166

1 reference

Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?

26 June 2017

1 reference

12 December 2020

A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial

1 reference

12 December 2020

Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.

1 reference

12 December 2020

Chemotherapy in the management of patients with inoperable non-small cell lung cancer

1 reference

12 December 2020

Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK).

1 reference

12 December 2020

Assessment of 'quality of life' using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer.

1 reference

12 December 2020

Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, meth

1 reference

12 December 2020

Patient-reported short-term and long-term physical and psychologic symptoms: results of the continuous hyperfractionated accelerated [correction of acclerated] radiotherapy (CHART) randomized trial in non-small-cell lung cancer. CHART Steering Commi

1 reference

12 December 2020

Women with lung cancer: impact on quality of life

1 reference

12 December 2020

Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer

1 reference

12 December 2020

Effect sizes for interpreting changes in health status.

1 reference

12 December 2020

Quality of life in patients with lung cancer: a review of literature from 1970 to 1995.

1 reference

12 December 2020

Quality of life assessment in chemotherapy trials for non-small cell lung cancer: are theory and practice significantly different?

1 reference

12 December 2020

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

12 December 2020

The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials

1 reference

12 December 2020

Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life

1 reference

12 December 2020

Toxicity, physical function and everyday activity reported by patients with inoperable non-small cell lung cancer in a randomized trial (chemotherapy versus radiotherapy)

1 reference

12 December 2020

Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology

1 reference

12 December 2020

Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Ran

1 reference

12 December 2020

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study G

1 reference

12 December 2020

Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?

1 reference

12 December 2020

Measuring quality of life: an emerging science.

1 reference

12 December 2020

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. Medical Research Council Lung Cancer Working Part

1 reference

12 December 2020

Managing patients with lung cancer. New guidelines should improve standards of care

1 reference

12 December 2020

A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Canc

1 reference

12 December 2020

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

12 December 2020

Improving quality of life in patients with non-small cell lung cancer: research experience with gemcitabine

1 reference

12 December 2020

Quality of life in lung cancer patients: as an important prognostic factor

1 reference

12 December 2020

Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data

1 reference

12 December 2020

Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party

1 reference

12 December 2020

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews

1 reference

12 December 2020

Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report

1 reference

12 December 2020

Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party

1 reference

12 December 2020

New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions

1 reference

12 December 2020

Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.

1 reference

12 December 2020

Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1022232624891

1 reference

Dimensions Publication ID

26 June 2017

0 references

1 reference